MedTrace Logo

Treatment of Severe Limb Ischemia With Autologous Bonemarrow Derived Mononuclear Cells

NCT00442143 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2010-07-23

No results posted yet for this study

Summary

The aim of the study is to investigate whether implantation of autologous bone marrow derived stem cells in ishemics limbs will improve vascularization

Conditions

  • Ischemia

Interventions

PROCEDURE

Stem cell implantation

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Moustapha Kassem, MD · Department of endocrinology M, Odense University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Completion
2007-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00442143 on ClinicalTrials.gov